AwesomeCapital
Search This Blog
Tuesday, March 3, 2020
Magenta Therapeutics EPS in-line
Magenta Therapeutics (NASDAQ:
MGTA
): Q4 GAAP EPS of -$0.59 in-line.
Cash, cash equivalents and marketable securities of $145.73M.
Press Release
https://seekingalpha.com/news/3547951-magenta-therapeutics-eps-in-line
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.